SCHEMBL5197914

SCHEMBL5197914

COc1ccc(OC)c([C]2CC2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.56
▸ CA1 P00915 1/20 0.56
▸ CA2 P00918 1/20 0.56
▸ CA7 P43166 1/20 0.56
▸ CA9 Q16790 1/20 0.56
▸ CA14 Q9ULX7 1/20 0.56
▸ ALDH1A1 P00352 7/20 0.48
▸ MAPT P10636 4/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ THRB P10828 1/20 0.48
▸ HDAC4 P56524 2/20 0.47
▸ HDAC2 Q92769 2/20 0.47
▸ HDAC8 Q9BY41 2/20 0.47
▸ HPGD P15428 3/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ CYP2D6 P10635 2/20 0.46
▸ APP P05067 1/20 0.46
▸ SNCA P37840 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL196223 0.84 CA12 (0.68) CA12CA1CA2CA7CA9
SCHEMBL10388011 0.83 CYP1A1 (0.58) CA12CA1CA2CA7CA9
SCHEMBL29899709 0.78 CA12 (0.60) CA12CA1CA2CA7CA9
SCHEMBL21408274 0.78 ERN1 (0.45) KDM4ETSHRNFE2L2
SCHEMBL6163752 0.77 KDM4E (0.60) CA12CA1CA2CA7CA9
SCHEMBL16109474 0.75 HDAC4 (0.65) CA12CA1CA2CA7CA9
SCHEMBL8503322 0.73 CA12 (0.65) CA12CA1CA2CA7CA9
SCHEMBL10841088 0.73 HDAC4 (0.54) CA12CA1CA2CA7CA9
SCHEMBL29384037 0.73 CYP1A1 (0.72) CA12CA1CA2CA7CA9
SCHEMBL29572032 0.73 KDM4E (0.64) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1844042-A1 INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS GENELABS TECHNOLOGIES, INC. (US) 2007-10-17 — — EP disclosed
WO-2006076529-A1 INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS GENELABS TECHNOLOGIES, INC. (US) 2006-07-20 — — WO disclosed
Send feedback